PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34715171-9	2022	Furthermore, sevoflurane decreased the expression of NMDA receptor subunits NR2A and NR2B, as well as PSD-95 in the hippocampus at P15 and those effects of sevoflurane were abolished by T3 administration.	Sevoflurane	13-24	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	76-80	
34715171-9	2022	Furthermore, sevoflurane decreased the expression of NMDA receptor subunits NR2A and NR2B, as well as PSD-95 in the hippocampus at P15 and those effects of sevoflurane were abolished by T3 administration.	Sevoflurane	156-167	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	76-80	
34223957-0	2021	Neuroprotection of sevoflurane against ischemia/reperfusion-induced brain injury through inhibiting GluN2A/GluN2B-PSD-95-MLK3 module.	Sevoflurane	19-30	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	100-106	
34223957-1	2021	To investigate the role of GluN2A and GluN2B in neuroprotective effect of sevoflurane preconditioning against cerebral ischemia-reperfusion injury (CIRI).	Sevoflurane	74-85	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	27-33	
34223957-5	2021	Sevoflurane preconditioning inhibits the tyrosine phosphorylation of GluN2A/GluN2B, the interaction of GluN2A/GluN2B-PSD-95-MLK3 and the phosphorylation of MLK3, MKK7 and JNK3 in rat hippocampus.	Sevoflurane	0-11	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	69-75	
34223957-5	2021	Sevoflurane preconditioning inhibits the tyrosine phosphorylation of GluN2A/GluN2B, the interaction of GluN2A/GluN2B-PSD-95-MLK3 and the phosphorylation of MLK3, MKK7 and JNK3 in rat hippocampus.	Sevoflurane	0-11	glutamate ionotropic receptor NMDA type subunit 2A	Rattus norvegicus	103-109